Sulforaphane treatment of autism spectrum disorder (ASD). - Test2 - elhamkhani - TriplyDB

Sulforaphane treatment of autism spectrum disorder (ASD).

Sulforaphane treatment of autism spectrum disorder (ASD).

http://www.wikidata.org/entity/Q34442394

about

Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism The spatiotemporal regulation of the Keap1-Nrf2 pathway and its importance in cellular bioenergetics Pharmacology and Clinical Drug Candidates in Redox Medicine Role of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanin confers stress resilience in mice Approaches to studying and manipulating the enteric microbiome to improve autism symptoms Placebo-like response in absence of treatment in children with Autism.Frugal chemoprevention: targeting Nrf2 with foods rich in sulforaphane Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial.Dietary Intake of Sulforaphane-Rich Broccoli Sprout Extracts during Juvenile and Adolescence Can Prevent Phencyclidine-Induced Cognitive Deficits at Adulthood Sulforaphane Bioavailability from Glucoraphanin-Rich Broccoli: Control by Active Endogenous Myrosinase Phase 1 Study of a Sulforaphane-Containing Broccoli Sprout Homogenate for Sickle Cell Disease Sulforaphane improves the bronchoprotective response in asthmatics through Nrf2-mediated gene pathways.Broccoli-Derived Sulforaphane and Chemoprevention of Prostate Cancer: From Bench to Bedside.Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes.Nrf2 Regulates the Sensitivity of Mouse Keratinocytes to Nitrogen Mustard via Multidrug Resistance-Associated Protein 1 (Mrp1)Identification of chemicals that mimic transcriptional changes associated with autism, brain aging and neurodegeneration.Vitamin D and omega-3 fatty acid supplements in children with autism spectrum disorder: a study protocol for a factorial randomised, double-blind, placebo-controlled trial.Sulforaphane, a Dietary Isothiocyanate, Induces G₂/M Arrest in Cervical Cancer Cells through CyclinB1 Downregulation and GADD45β/CDC2 Association.Current potential health benefits of sulforaphane.Aging-related decline in the induction of Nrf2-regulated antioxidant genes in human bronchial epithelial cells.Is Taurine a Biomarker in Autistic Spectrum Disorder?Psychopharmacological interventions in autism spectrum disorder.Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia.Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants.Hormesis, cellular stress response, and redox homeostasis in autism spectrum disorders.Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?New Assessments and Treatments in ASD.Autism Behavior Inventory: A Novel Tool for Assessing Core and Associated Symptoms of Autism Spectrum Disorder.Evidence of Mitochondrial Dysfunction in Autism: Biochemical Links, Genetic-Based Associations, and Non-Energy-Related Mechanisms.Altered kynurenine pathway metabolism in autism: Implication for immune-induced glutamatergic activity.Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane.Dietary Supplement for Core Symptoms of Autism Spectrum Disorder: Where Are We Now and Where Should We Go?The role of oxidative stress, inflammation and acetaminophen exposure from birth to early childhood in the induction of autism.Uncommon use of common measures in sulforaphane trial.Reply to Scahill: Behavioral outcome measures in autism.Sulforaphane epigenetically enhances neuronal BDNF expression and TrkB signaling pathways.Sulforaphane from Broccoli Reduces Symptoms of Autism: A Follow-up Case Series from a Randomized Double-blind Study.Decreased total antioxidant capacity has a larger effect size than increased oxidant levels in urine in individuals with autism spectrum disorder.

P2860

Q26744037-6C11040A-13A9-49C2-A032-F73663328522 Q26746354-D72B0061-32A6-44FF-9234-FA201C681B69 Q26778362-9B6F7CAB-BBA4-4507-8D91-625C0051D329 Q26778368-6E8AE7AB-49DC-47C9-BFBD-EB5C81F62BC2 Q26785525-5B08874B-9D9A-4034-B96A-DA09FDFF127A Q28385414-92FB52F4-4334-4A07-929D-3B63E3878D63 Q30410992-A9E7FBA0-8A63-493C-8EE4-06800AB41776 Q33453967-9AC95E2A-289F-4A12-AF19-4A193077944C Q34517865-52F49E48-2687-4F2B-B4CE-19D5EC8467FF Q34542848-89359C2F-C014-4082-8457-7A82CD00BC26 Q35673126-A77C276B-CD23-42C6-BC82-8F1B0E9644FE Q35829255-BF43E9B5-ECA6-4A6E-B85D-AD4CEFC135DC Q35987429-3A58A7F0-AAC3-4980-95B9-86D2A7347580 Q36060130-C8410180-0642-449F-83D4-C5A82D5C4C78 Q36255185-4C41E4A0-7C64-4AA6-837B-8014F9A6EC02 Q36405748-CE247478-ABD7-43D3-8DF4-18BC95723359 Q36468929-832C1468-127F-4628-91EA-F5FCFA5D7BE2 Q36768298-87842E0D-3CC2-4747-8382-BA40A61EFABE Q37031006-2319A947-6438-41C4-A486-33E0A4C5360A Q37286572-BE3B9746-2594-485E-9B8A-03FDA9D36F97 Q37579346-147FE70F-E3D0-41BC-91CC-E579CA16BC12 Q38597772-DA73CAF3-DA5D-4CB8-8D88-963E2D775E87 Q38604354-7D88E4E3-87D0-4540-8E80-EE8544314D82 Q38739577-CA6C55AD-7D43-4D05-9AE0-EF8747FCEBBE Q38743021-AADDD7FA-583A-483C-A108-F60EF3C3C402 Q38920601-DE47B310-AAFF-4E58-8AFC-65FBE698BFF2 Q38958315-E3AA4F21-69CD-441A-B413-FA751250878D Q38963019-07D2A493-B6D2-4E47-A122-F8437061684E Q39157674-396C5A78-B6DC-4A65-B56F-B1499E8798B9 Q39302206-33D1BA86-7392-46E6-81F9-AB6963EB6DD2 Q39384617-8A563233-5AD9-4F92-8CBD-875252F5D335 Q40397762-50C79F55-00AB-4C9B-B996-9336109653F3 Q40987646-D2C5662F-AF8D-4089-B9F7-438643F296FC Q41526064-D30CB9D8-D3DE-4BC3-9DBE-1E2DC1E43CBC Q42340206-69939F17-D181-47D9-8F6D-DB72ED19B099 Q43126752-B6A0A9EF-9060-4306-84AB-8CC5581F19D8 Q43126774-A7FA48C7-3994-483D-9D23-3031824A560A Q43650001-9A4DA81E-7C4D-4F5E-AC12-171D870DBCB9 Q47111441-784CB24E-0C5B-4B9D-BB34-0E71E0E4DE12 Q47232269-6705D7A8-C84A-430D-B502-ACF25A79A60D

P2860

Sulforaphane treatment of autism spectrum disorder (ASD).

http://www.wikidata.org/entity/Q34442394

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Sulforaphane treatment of autism spectrum disorder (ASD).

@ast

Sulforaphane treatment of autism spectrum disorder (ASD).

@en

Sulforaphane treatment of autism spectrum disorder

@nl

type

label

Sulforaphane treatment of autism spectrum disorder (ASD).

@ast

Sulforaphane treatment of autism spectrum disorder (ASD).

@en

Sulforaphane treatment of autism spectrum disorder

@nl

prefLabel

Sulforaphane treatment of autism spectrum disorder (ASD).

@ast

Sulforaphane treatment of autism spectrum disorder (ASD).

@en

Sulforaphane treatment of autism spectrum disorder

@nl

P1433

Q34442394-8FCF41C9-45E5-4512-84DA-5EE617B7332B

P1476

Q34442394-5C195717-86E6-4809-B297-4DA124159D8C

P2093

Q34442394-116A249B-DF73-478E-8E47-0B0FFEA08822

Q34442394-1D510B8C-5719-4878-8EBD-D4C8268B5F9F

Q34442394-3587856A-76F2-4CC0-A1FD-26F315FE8BE6

Q34442394-5DFA41EB-9DCD-4D56-ABF8-05D5CEF3F173

Q34442394-7F236977-A9A0-4D97-AC57-DEBA8CABBF8B

Q34442394-FF35D2A1-2BFB-4411-AD9C-8104BA3C587A

P2860

Q34442394-018476F5-76B2-42C8-97F0-CD7504DA2B15

Q34442394-0C559196-27E7-4546-B764-38355696DEB0

Q34442394-0F0FC7BC-A888-4878-9B74-BB3F01579751

Q34442394-1B6ED761-D6A2-4FB2-B0FE-FCB33E1832F1

Q34442394-214A600A-3700-4FD7-8DB8-CD05D1F4F7BC

Q34442394-21B94F3B-950D-4AF1-89CB-4F6E8717FABF

Q34442394-24A31F9F-F2BB-4D98-9BF4-81A5EA5BD04A

Q34442394-37CCFC0D-3C63-4F3A-B015-969CCDD4D321

Q34442394-3F327A81-858E-4F99-9A01-2FC61D21995D

Q34442394-45515533-1B54-41FE-A34F-814F83A1D049

P304

Q34442394-BB6FD3D9-AB98-4BB9-B69E-162E9E969E90

P31

Q34442394-7F2E1606-1523-4527-B9E6-682910ABD626

P356

Q34442394-C03E8A17-FFB8-494F-ABE0-A26D471517D8

P407

Q34442394-045276BB-7037-4489-B9E4-79114E96BB70

P433

Q34442394-0C0D49C0-09CB-4CD7-AA7D-C6383BBA0CB2

P478

Q34442394-64154A7D-D40D-4B05-BD8A-117BB8561F30

P50

Q34442394-EAFB90D6-2CB5-450B-A248-5860C8CCCC8D

P577

Q34442394-E986B8E0-49FA-4ADB-8AE2-9A0AB0AAD310

P5875

Q34442394-6134C95C-6275-4B62-B18F-59ECEAC3C671

P698

Q34442394-C754F997-1431-4731-A166-7E9F05638771

P921

Q34442394-094E2338-335C-4C48-A144-1EC56A5E48D0

Q34442394-E6080B6A-5733-4943-98F3-F0354C724D91

P932

Q34442394-A9CD686B-1221-4E6E-80C3-2B5D90EE240F

P356

PNAS.1416940111

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Sulforaphane treatment of autism spectrum disorder (ASD).

@en

P2093

Andrew W Zimmerman

http://www.w3.org/2001/XMLSchema#string

Jed W Fahey

http://www.w3.org/2001/XMLSchema#string

Kanwaljit Singh

http://www.w3.org/2001/XMLSchema#string

Kirby D Smith

http://www.w3.org/2001/XMLSchema#string

Paul Talalay

http://www.w3.org/2001/XMLSchema#string

Susan L Connors

http://www.w3.org/2001/XMLSchema#string

P2860

Maternal lifestyle and environmental risk factors for autism spectrum disorders

Autism, fever, epigenetics and the locus coeruleus

A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure

Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates

Notes from the field: "green" chemoprevention as frugal medicine

Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China

Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010

Neuroglial activation and neuroinflammation in the brain of patients with autism

Heat shock proteins: cellular and molecular mechanisms in the central nervous system.

Child health, developmental plasticity, and epigenetic programming

P304

15550-15555

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1416940111

http://www.w3.org/2001/XMLSchema#string

P407

P433

43

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267756086

http://www.w3.org/2001/XMLSchema#string

P698

25313065

http://www.w3.org/2001/XMLSchema#string

P921

Autism spectrum

P932

4217462

http://www.w3.org/2001/XMLSchema#string